← Eichor
Study identifier: NCT06055868 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

Condition: HIV Infections · Oral Squamous Cell Carcinoma · Oropharyngeal Squamous Cell Carcinoma  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants144
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.

This description comes directly from the study's public registry record.

Talk to the study team

William Juarez  ·  (415) 437-7439  ·  William.Juarez@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06055868